We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

108 hedge funds and large institutions have $123M invested in VanEck Biotech ETF in 2020 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 33 increasing their positions, 20 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

183% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 6

65% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 20

7% more funds holding

Funds holding: 101 → 108 (+7)

1.2% less ownership

Funds ownership: 26.85% → 25.65% (-1.2%)

7% less capital invested

Capital invested by funds: $131M → $123M (-$8.66M)

17% less call options, than puts

Call options by funds: $1.16M | Put options by funds: $1.39M

Holders
108
Holders Change
+7
Holders Change %
+6.93%
% of All Funds
1.91%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
33
Reduced
20
Closed
6
Calls
$1.16M
Puts
$1.39M
Net Calls
-$234K
Net Calls Change
-$721K

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$3.2M
2
Citadel Advisors
Citadel Advisors
Florida
+$2.65M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$2.04M
4
KAS
Kestra Advisory Services
Texas
+$886K
5
Cetera Investment Advisers
Cetera Investment Advisers
Illinois
+$576K

Top Sellers

Rank Fund Capital Flow
1
PAG
Pinnacle Advisory Group
Maryland
-$20.2M
2
HighTower Advisors
HighTower Advisors
Illinois
-$2.21M
3
FTUS
Flow Traders U.S.
New York
-$946K
4
LPL Financial
LPL Financial
California
-$407K
5
UBS Group
UBS Group
Switzerland
-$231K
Name Holding Trade Value Shares
Change 		Change in
Stake
Ameriprise
26
Ameriprise
Minnesota
$1.12M +$6.75K +41 +0.6%
Wells Fargo
27
Wells Fargo
California
$1.02M -$95.9K -582 -9%
RJFSA
28
Raymond James Financial Services Advisors
Florida
$1.02M -$68.4K -415 -6%
ACA
29
Atlas Capital Advisors
Wyoming
$1.02M – – –
GJIC
30
Gamble Jones Investment Counsel
California
$1.02M – – –
SBH
31
Segall Bryant & Hamill
Illinois
$873K +$8.24K +50 +1%
PNC Financial Services Group
32
PNC Financial Services Group
Pennsylvania
$869K -$12.4K -75 -1%
AL
33
Aspiriant LLC
California
$740K -$38.7K -235 -5%
FNBOSM
34
First National Bank of South Miami
Florida
$640K -$16.8K -102 -3%
IAMOG
35
Investors Asset Management of Georgia
Georgia
$628K – – –
SC
36
Scotia Capital
Ontario, Canada
$610K -$78.6K -477 -12%
Cetera Investment Advisers
37
Cetera Investment Advisers
Illinois
$593K +$576K +3,494 New
Truist Financial
38
Truist Financial
North Carolina
$582K +$329 +2 +0.1%
Northern Trust
39
Northern Trust
Illinois
$569K +$338K +2,053 +158%
HPCM
40
Hunter Perkins Capital Management
Illinois
$556K +$540K +3,279 New
WJWM
41
Williams Jones Wealth Management
New York
$536K – – –
Bank of New York Mellon
42
Bank of New York Mellon
New York
$527K +$20.6K +125 +4%
TC
43
Telemus Capital
Michigan
$518K +$20.6K +125 +4%
Cambridge Investment Research Advisors
44
Cambridge Investment Research Advisors
Iowa
$516K +$48.8K +296 +11%
PAG
45
Private Advisor Group
New Jersey
$493K – – –
NWA
46
Navis Wealth Advisors
New York
$482K +$468K +2,839 New
Verition Fund Management
47
Verition Fund Management
Connecticut
$417K +$405K +2,459 New
Osaic Holdings
48
Osaic Holdings
Arizona
$378K -$17.6K -107 -5%
BPA
49
Beacon Pointe Advisors
California
$373K – – –
FFN
50
Focus Financial Network
Minnesota
$320K +$659 +4 +0.2%
1
2
3 4 5

BBH Hedge Fund Activity: Q4 2020 in Review

108 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q4 2020, worth a combined $123M — down 6.6% from $131M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new BBH positions and 6 closed out — a net gain of 11 holders — while 33 added to existing stakes and 20 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $3.2M. The largest seller was Pinnacle Advisory Group, exiting entirely with an estimated $20.2M sold.

  • 108 institutional investors held VanEck Biotech ETF (BBH) as of Q4 2020, up from 101 in Q3 2020.
  • Funds reported $123M of VanEck Biotech ETF stock for Q4 2020, down 6.6% quarter-over-quarter.
  • 17 funds opened new VanEck Biotech ETF positions in Q4 2020 and 6 closed out, a net change of +11 holders.
  • The largest VanEck Biotech ETF buyer in Q4 2020 was Goldman Sachs, an estimated $3.2M added.
  • The largest VanEck Biotech ETF seller in Q4 2020 was Pinnacle Advisory Group, an estimated $20.2M sold.

Based on aggregated 13F filings for Q4 2020.